Q4 2025 Holdings
Filed 2026-02-17 | 34 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $230.0M | 5,220,846 | 16.9% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $167.1M | 677,705 | 12.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $153.5M | 8,093,908 | 11.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $128.0M | 4,034,070 | 9.4% |
| Immunome Inc(IMNM) | COM | 45257U108 | $122.8M | 5,718,385 | 9.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $62.9M | 4,368,804 | 4.6% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $55.3M | 15,666,731 | 4.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $51.1M | 1,437,918 | 3.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $50.5M | 10,050,644 | 3.7% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $35.6M | 1,285,859 | 2.6% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $30.1M | 1,459,599 | 2.2% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $30.0M | 885,927 | 2.2% |
| Absci Corporation(ABSI) | COM | 00091E109 | $28.8M | 8,253,316 | 2.1% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $28.3M | 3,163,256 | 2.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $25.7M | 742,017 | 1.9% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $20.2M | 5,539,724 | 1.5% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $13.2M | 2,164,777 | 1.0% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $12.9M | 491,654 | 1.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $12.6M | 12,872,946 | 0.9% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $10.7M | 1,099,756 | 0.8% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $10.5M | 549,840 | 0.8% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $10.5M | 1,860,542 | 0.8% |
| Ceribell Inc(CBLL) | COM | 15678C102 | $9.5M | 435,239 | 0.7% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $8.2M | 112,664 | 0.6% |
| Atara Biotherapeutics Inc(ATRA) | COM NEW | 046513206 | $8.0M | 441,701 | 0.6% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $7.7M | 283,308 | 0.6% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $7.3M | 118,054 | 0.5% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $6.6M | 2,681,159 | 0.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.0M | 133,882 | 0.4% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $4.1M | 1,586,174 | 0.3% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $3.7M | 3,264,718 | 0.3% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $3.7M | 448,110 | 0.3% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $2.0M | 1,616,228 | 0.1% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $700.1K | 82,955 | 0.1% |